STAT+: Katherine Szarama named acting director of FDA’s vaccines and biologics center
Stat News • 4/30/2026 – 5/1/2026
Summary
Katherine Szarama has been named acting director of the FDA’s Center for Biologics Evaluation and Research (CBER). She previously served as deputy to Vinay Prasad, who she is succeeding in this role.
Advertisement
Lindy Score Breakdown (V4.2)
15h
Age
1
Sources
from cluster
3
Hours Since Seen
Final Score12/100
CategoryAntiLindy
StatusActive
Recency Multiplier96% (0.5^3/48)
Hero EligibleYes
Score BreakdownRisk 70
Source Reputation: Low-trust source (4/20 pts)
Consensus: Single source - no independent confirmation yet
Age: Breaking news - too recent to assess longevity
Stories gain Lindy status through source reputation, network consensus, and time survival.
Breaking Similar stories
STAT+: Democrats go hard on health care affordability
Stat News • 1 day ago
STAT+: Pharmalittle: We’re reading about a Supreme Court hearing on ‘skinny labels,’ AstraZeneca U.K. expansion, and more
Stat News • 1 day ago
STAT+: AIDS group sues Trump administration over undisclosed agreement with Gilead
Stat News • 2 days ago
STAT+: Hinge has a new FDA-cleared migraine device
Stat News • Today
STAT+: Health system CEOs get off easy at Congressional hearing on affordability
Stat News • 2 days ago
STAT+: Why conversations around health AI may be evolving beyond hype
Stat News • 1 day ago
STAT+: OxyContin maker Purdue Pharma set to dissolve after judge approves its criminal sentence
Stat News • Today
STAT+: New obesity tool aims to predict risk of 18 serious complications
Stat News • 1 day ago
STAT+: Five-way obesity drug is super effective — in mice
Stat News • Today
STAT+: As artificial intelligence shows off diagnostic chops, scientists reckon with the way forward
Stat News • Today
